[Federal Register: August 29, 2006 (Volume 71, Number 167)]
[Notices]               
[Page 51198]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29au06-47]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Psychopharmacologic Drugs Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Psychopharmacologic Drugs Advisory 
Committee scheduled for September 7, 2006, is cancelled. This amended 
meeting was announced in the Federal Register of August 17, 2006 (71 FR 
47502).

FOR FURTHER INFORMATION CONTACT: Cicely Reese, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-
mail: cicely.reese@fda.hhs.gov, or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512544. Please call the Information Line for up-to-date information 
on this meeting.

    Dated: August 23, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-14293 Filed 8-28-06; 8:45 am]

BILLING CODE 4160-01-S